Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflict of interest.
All procedures performed in this report were in accordance with ethical standards of our institute and with the 1964 Helsinki declaration and its later amendments.
Informed consent was obtained from the patient described.
- 2.Abedi F, Borovik AM, Waring D, Hariz S, Francis IC (2019) Primary intraocular natural killer/T-cell lymphoma unmasked with infective endophthalmitis after an intravitreal injection of bevacizumab. Clin Exp Ophthalmol:1–2Google Scholar
- 6.Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K (2009) Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 27:5594–5600CrossRefGoogle Scholar
- 8.Shenkier TN, Blay J-Y, O’Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O’Brien P, Rubenstein J, Connors JM (2005) Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23:2233–2239CrossRefGoogle Scholar
- 9.Yamaguchi M, Kwong Y-L, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29:4410–4416CrossRefGoogle Scholar